Theravance Biopharma (TBPH) Other Working Capital Changes (2017 - 2023)
Theravance Biopharma (TBPH) posted quarterly Other Working Capital Changes of -$2.2 million for Q1 2026, down 3333.82% year-over-year from $68000.0 in Q1 2025, and down 141.55% quarter-over-quarter from $5.3 million in Q4 2025.
Powered by 
Analysis
Theravance Biopharma (TBPH) Other Working Capital Changes (2017 - 2023) Analysis & Trends
Theravance Biopharma (TBPH) has reported Other Working Capital Changes for 13 consecutive years, with -$2.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 3333.82% year-over-year to -$2.2 million; the TTM figure through Mar 2026 stood at -$2.2 million (down 337.38% YoY), while the FY2025 annual figure was $67000.0, up 112.59% from the prior year.
- Other Working Capital Changes declined to -$2.2 million in Q1 2026 per TBPH's latest filing, from $5.3 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $4.5 million in Q4 2023 and bottomed at -$1.6 million in Q3 2023.
- Historically, Other Working Capital Changes has averaged $275058.8 across 5 years, with a median of -$144000.0 in 2024.
- Annual changes were most pronounced in 2025 — Other Working Capital Changes jumped 1020.35% — and 2026, when it slumped 3333.82%.
- Theravance Biopharma's Other Working Capital Changes stood at -$838000.0 in 2022, then surged by 232.82% to $1.1 million in 2023, then slumped by 151.66% to -$575000.0 in 2024, then surged by 1020.35% to $5.3 million in 2025, then plunged by 141.55% to -$2.2 million in 2026.
- Business Quant data shows TBPH's Other Working Capital Changes at -$2.2 million in Q1 2026, $5.3 million in Q4 2025, and -$5.3 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Theravance Biopharma | 882.99 Mn | 495.33 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -199,000.00 |
| Dec 31, 2023 | -199,000.00 |
| Sep 30, 2023 | -6,000.00 |
| Sep 30, 2023 | -6,000.00 |
| Jun 30, 2023 | -5,000.00 |
| Jun 30, 2023 | -5,000.00 |
| Mar 31, 2023 | -6,000.00 |
| Mar 31, 2023 | -6,000.00 |
| Dec 31, 2022 | -6,000.00 |
| Dec 31, 2022 | -6,000.00 |
| Sep 30, 2022 | -6,000.00 |
| Sep 30, 2022 | -6,000.00 |
| Jun 30, 2022 | -171,000.00 |
| Jun 30, 2022 | -171,000.00 |
| Mar 31, 2022 | -9,000.00 |
| Mar 31, 2022 | -9,000.00 |
| Dec 31, 2021 | -2.82 Mn |
| Dec 31, 2021 | -2.82 Mn |
| Sep 30, 2021 | -2.80 Mn |
| Sep 30, 2021 | -2.80 Mn |